BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 30258108)

  • 1. CD163, a novel therapeutic target, regulates the proliferation and stemness of glioma cells via casein kinase 2.
    Chen T; Chen J; Zhu Y; Li Y; Wang Y; Chen H; Wang J; Li X; Liu Y; Li B; Sun X; Ke Y
    Oncogene; 2019 Feb; 38(8):1183-1199. PubMed ID: 30258108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of gliomagenesis and stemness through acid sensor ASIC1a.
    King P; Wan J; Guo AA; Guo S; Jiang Y; Liu M
    Int J Oncol; 2021 Oct; 59(4):. PubMed ID: 34515325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular markers of neuro-oncogenesis in patients with glioblastoma.
    Kopylov AM; Antipova OA; Pavlova GV
    Zh Vopr Neirokhir Im N N Burdenko; 2022; 86(6):99-105. PubMed ID: 36534630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Glioma Cells Exhibit Stem Cell-like Properties.
    Liu T; Xu H; Huang M; Ma W; Saxena D; Lustig RA; Alonso-Basanta M; Zhang Z; O'Rourke DM; Zhang L; Gong Y; Kao GD; Dorsey JF; Fan Y
    Cancer Res; 2018 Dec; 78(23):6632-6642. PubMed ID: 30322863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the Gene Expression Rules That Define the Subtypes in Glioma.
    Cai YD; Zhang S; Zhang YH; Pan X; Feng K; Chen L; Huang T; Kong X
    J Clin Med; 2018 Oct; 7(10):. PubMed ID: 30322114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. circPTN sponges miR-145-5p/miR-330-5p to promote proliferation and stemness in glioma.
    Chen J; Chen T; Zhu Y; Li Y; Zhang Y; Wang Y; Li X; Xie X; Wang J; Huang M; Sun X; Ke Y
    J Exp Clin Cancer Res; 2019 Sep; 38(1):398. PubMed ID: 31511040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Environmentally Self-Adaptative Nanocarriers Suppress Glioma Proliferation and Stemness via Codelivery of shCD163 and Doxorubicin.
    Liu J; Zhang Y; Chen T; Chen H; He H; Jin T; Wang J; Ke Y
    ACS Appl Mater Interfaces; 2020 Nov; 12(47):52354-52369. PubMed ID: 33196179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and clinical characterization of CD163 expression via large-scale analysis in glioma.
    Liu S; Zhang C; Maimela NR; Yang L; Zhang Z; Ping Y; Huang L; Zhang Y
    Oncoimmunology; 2019; 8(7):1601478. PubMed ID: 31143523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCL8 secreted by tumor-associated macrophages promotes invasion and stemness of glioblastoma cells via ERK1/2 signaling.
    Zhang X; Chen L; Dang WQ; Cao MF; Xiao JF; Lv SQ; Jiang WJ; Yao XH; Lu HM; Miao JY; Wang Y; Yu SC; Ping YF; Liu XD; Cui YH; Zhang X; Bian XW
    Lab Invest; 2020 Apr; 100(4):619-629. PubMed ID: 31748682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive gene expression meta-analysis identifies signature genes that distinguish microglia from peripheral monocytes/macrophages in health and glioma.
    Haage V; Semtner M; Vidal RO; Hernandez DP; Pong WW; Chen Z; Hambardzumyan D; Magrini V; Ly A; Walker J; Mardis E; Mertins P; Sauer S; Kettenmann H; Gutmann DH
    Acta Neuropathol Commun; 2019 Feb; 7(1):20. PubMed ID: 30764877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective exosome exclusion of miR-375 by glioma cells promotes glioma progression by activating the CTGF-EGFR pathway.
    Xu X; Liu Y; Li Y; Chen H; Zhang Y; Liu J; Deng S; Zheng Y; Sun X; Wang J; Chen T; Huang M; Ke Y
    J Exp Clin Cancer Res; 2021 Jan; 40(1):16. PubMed ID: 33407703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGFBP2 promotes vasculogenic mimicry formation via regulating CD144 and MMP2 expression in glioma.
    Liu Y; Li F; Yang YT; Xu XD; Chen JS; Chen TL; Chen HJ; Zhu YB; Lin JY; Li Y; Xie XM; Sun XL; Ke YQ
    Oncogene; 2019 Mar; 38(11):1815-1831. PubMed ID: 30368528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infiltration of CD163-positive macrophages in glioma tissues after treatment with anti-PD-L1 antibody and role of PI3Kγ inhibitor as a combination therapy with anti-PD-L1 antibody in in vivo model using temozolomide-resistant murine glioma-initiating cells.
    Miyazaki T; Ishikawa E; Matsuda M; Sugii N; Kohzuki H; Akutsu H; Sakamoto N; Takano S; Matsumura A
    Brain Tumor Pathol; 2020 Apr; 37(2):41-49. PubMed ID: 31980975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering Nanomedicine for Non-Viral RNA-Based Gene Therapy of Glioblastoma.
    He W; Wang N; Wang Y; Liu M; Qing Q; Su Q; Zou Y; Liu Y
    Pharmaceutics; 2024 Apr; 16(4):. PubMed ID: 38675144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a CD163-Targeted PET Radiotracer That Images Resident Macrophages in Atherosclerosis.
    Zhang X; Heo GS; Li A; Lahad D; Detering L; Tao J; Gao X; Zhang X; Luehmann H; Sultan D; Lou L; Venkatesan R; Li R; Zheng J; Amrute J; Lin CY; Kopecky BJ; Gropler RJ; Bredemeyer A; Lavine K; Liu Y
    J Nucl Med; 2024 May; 65(5):775-780. PubMed ID: 38548349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spatial structure of the tumor immune microenvironment can explain and predict patient response in high-grade serous carcinoma.
    Van Kleunen L; Ahmadian M; Post MD; Wolsky RJ; Rickert C; Jordan K; Hu J; Richer JK; Marjon NA; Behbakht K; Sikora MJ; Bitler BG; Clauset A
    bioRxiv; 2024 Jan; ():. PubMed ID: 38352574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-associated macrophages and PD-L1 in prostate cancer: a possible key to unlocking immunotherapy efficacy.
    Wang J; Wu W; Yuan T; Wang L; Zang L; Liu Q; Wang L; Huo X; Huo B; Tang Y; Wang H; Zhao Z
    Aging (Albany NY); 2024 Jan; 16(1):445-465. PubMed ID: 38189834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Targeted Therapies in Glioblastoma Multiforme: A Systematic Overview of Global Trends and Findings.
    Begagić E; Pugonja R; Bečulić H; Čeliković A; Tandir Lihić L; Kadić Vukas S; Čejvan L; Skomorac R; Selimović E; Jaganjac B; Juković-Bihorac F; Jusić A; Pojskić M
    Brain Sci; 2023 Nov; 13(11):. PubMed ID: 38002561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Overview of CD133 as a Functional Unit of Prognosis and Treatment Resistance in Glioblastoma.
    Joyce T; Jagasia S; Tasci E; Camphausen K; Krauze AV
    Curr Oncol; 2023 Sep; 30(9):8278-8293. PubMed ID: 37754516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic Review of Molecular Targeted Therapies for Adult-Type Diffuse Glioma: An Analysis of Clinical and Laboratory Studies.
    Muzyka L; Goff NK; Choudhary N; Koltz MT
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.